# Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00690482** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 118 (actual)

## Conditions studied

- Moderate to Severe COPD

## Interventions

- **DRUG:** AZD1981
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00690482
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2014-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690482, "Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00690482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*